CXCL3/GRO Gamma Rekombinanter Antikörper

CXCL3/GRO Gamma Rekombinant Antikörper für WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, ELISA

Konjugation

Unkonjugiert

CloneNo.

250114C9

Kat-Nr. : 86261-1-RR

Synonyme

CXCL/GRO Gamma, CXCL3, C X C motif chemokine 3, C-X-C motif chemokine 3, GRO gamma

---

• 

  WB analysis of RAW 264.7 using 86261-1-RR

  RAW 264.7 cells were subjected to SDS PAGE followed by western blot with 86261-1-RR (CXCL3 antibody) at dilution of 1:10000 incubated at room temperature for 1.5 hours.

• 

  WB analysis using 86261-1-RR

  Various lysates were subjected to SDS PAGE followed by western blot with 86261-1-RR (CXCL3 antibody) at dilution of 1:10000 incubated at room temperature for 1.5 hours.

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: RAW 264.7-Zellen, A549-Zellen, Rattenlungengewebe

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:5000-1:50000

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Produktinformation

86261-1-RR bindet in WB, ELISA CXCL3/GRO Gamma und zeigt Reaktivität mit human, Maus, Ratten

• Getestete Reaktivität: human, Maus, Ratte
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Rekombinant
• Typ: Antikörper
• Immunogen: CXCL3/GRO Gamma fusion protein Eg2982
• Vollständiger Name: chemokine (C-X-C motif) ligand 3
• Berechnetes Molekulargewicht: 11 kDa
• Beobachtetes Molekulargewicht: 11 kDa
• GenBank-Zugangsnummer: NM_002090.3
• Gene symbol: CXCL3
• Gene ID (NCBI): 2921
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Protein-A-Reinigung
• Lagerungspuffer: PBS with 0.02% sodium azide and 50% glycerol
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

CXC chemokine ligand 3 (CXCL3) is a member of CXC-type chemokine family that is identified as a major regulator in immune and inflammation responses. CXCL3 is broadly expressed in various human tumor types, and it is also known to play a critical role in mediating tumor development and progression.